Collectively, these results provide new evidence that these three factors (Lig3, Lig1, and PARP1) have a functional role in MYCN oncogenic activity in human NCSC, and sets precedence to investigate alt-NHEJ and non-canonical DNA repair factors in NBL tumor initiation and progression. This evidence concerns the gene LIG1 and neoplasm.